Drugs / NYVAC-C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00490074 | Jul 2007 → Dec 2008 | HIV infectious disease | ANRS, Emerging Infectious Diseases | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NYVAC-C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00490074 ↗ |
| Modality | Vaccine | “Volunteers will be vaccinated by DNA-C and NYVAC-C vaccines” NCT00490074 ↗ |
| Route | Intramuscular | “NYVAC-C: 1 ml intramuscular in non-dominant deltoid” NCT00490074 ↗ |